Atlas Trials

First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer

Clinical trial NCT00673504 · COMPLETED

Trial details

NCT number
NCT00673504
Sponsor
Central European Society for Anticancer Drug Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2008-04-01
Primary completion
2011-10-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.